Arcturus Therapeutics
ARCT
11,11 €
Share price
0.42%
Change (1 day)
-63.37%
Change (1 year)
Operating Margin for Arcturus Therapeutics (ARCT)
Operating Margin as of March 2025 (TTM): -52.91%
According to Arcturus Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -52.91%. At the end of 2024 the company had an Operating Margin of -58.49%.
Operating Margin history for Arcturus Therapeutics from 2018 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -58.49% | 230.83% |
| 2023 | -17.68% | -441.77% |
| 2022 | 5.17% | -100.31% |
| 2021 | -1,647.98% | 117.89% |
| 2020 | -756.35% | 504.97% |
| 2019 | -125.02% | -9.59% |
| 2018 | -138.29% | 64.89% |
| 2017 | -83.87% | 1012.87% |
| 2016 | -7.54% | -75.67% |
| 2015 | -30.97% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 22.85% | -143.19% | 🇺🇸 USA |
 | -234,760.00% | 443,596.84% | Bahamas |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.